1. Home
  2. EBS vs LXFR Comparison

EBS vs LXFR Comparison

Compare EBS & LXFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EBS
  • LXFR
  • Stock Information
  • Founded
  • EBS 1998
  • LXFR 1898
  • Country
  • EBS United States
  • LXFR United States
  • Employees
  • EBS N/A
  • LXFR N/A
  • Industry
  • EBS Biotechnology: Pharmaceutical Preparations
  • LXFR Major Chemicals
  • Sector
  • EBS Health Care
  • LXFR Industrials
  • Exchange
  • EBS Nasdaq
  • LXFR Nasdaq
  • Market Cap
  • EBS 359.3M
  • LXFR 314.6M
  • IPO Year
  • EBS 2006
  • LXFR 2012
  • Fundamental
  • Price
  • EBS $7.16
  • LXFR $12.05
  • Analyst Decision
  • EBS Strong Buy
  • LXFR
  • Analyst Count
  • EBS 3
  • LXFR 0
  • Target Price
  • EBS $14.33
  • LXFR N/A
  • AVG Volume (30 Days)
  • EBS 1.4M
  • LXFR 118.7K
  • Earning Date
  • EBS 08-06-2025
  • LXFR 07-29-2025
  • Dividend Yield
  • EBS N/A
  • LXFR 4.32%
  • EPS Growth
  • EBS N/A
  • LXFR 49063.50
  • EPS
  • EBS N/A
  • LXFR 0.79
  • Revenue
  • EBS $965,400,000.00
  • LXFR $399,500,000.00
  • Revenue This Year
  • EBS N/A
  • LXFR $2.63
  • Revenue Next Year
  • EBS $16.15
  • LXFR $3.30
  • P/E Ratio
  • EBS N/A
  • LXFR $15.29
  • Revenue Growth
  • EBS N/A
  • LXFR 1.63
  • 52 Week Low
  • EBS $4.02
  • LXFR $9.41
  • 52 Week High
  • EBS $15.10
  • LXFR $15.64
  • Technical
  • Relative Strength Index (RSI)
  • EBS 53.48
  • LXFR 50.08
  • Support Level
  • EBS $6.89
  • LXFR $11.89
  • Resistance Level
  • EBS $7.83
  • LXFR $12.18
  • Average True Range (ATR)
  • EBS 0.37
  • LXFR 0.32
  • MACD
  • EBS -0.00
  • LXFR -0.06
  • Stochastic Oscillator
  • EBS 42.80
  • LXFR 33.67

About EBS Emergent Biosolutions Inc.

Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.

About LXFR Luxfer Holdings PLC

Luxfer Holdings PLC is a manufacturer industrial company innovating niche applications in materials engineering. It focuses on value creation by using its broad array of technical know-how and proprietary technologies to help create a safe, clean, and energy-efficient world. Luxfer's high-performance materials, components, and high-pressure gas containment devices are used in defense, first response and healthcare, transportation, and general industrial applications. It focuses on product lines related to magnesium alloys, zirconium chemicals, and carbon composites. Its segments are Elektron, Gas Cylinders, and Graphic Arts. It generates the majority of its revenue from Elektron and as well as Gas Cylinders.

Share on Social Networks: